Gartner Research

Hype Cycle for Life Science Research and Development, 2018

Published: 27 July 2018

ID: G00338494

Analyst(s): Jeff Smith , Michael Shanler


CIOs are transitioning into the execution phase of the digital R&D vision to enable new capabilities for developing new drugs, devices and therapies. Use this Hype Cycle to orchestrate building in new technologies with an expanding ecosystem of partners.

Table Of Contents


  • What You Need to Know
  • The Hype Cycle
  • The Priority Matrix
  • Off the Hype Cycle
  • On the Rise
    • AI-Enabled Material Informatics
    • eSource
    • Physician-Prescribed Clinical Apps
    • IoT-Enabled Laboratory
    • Blockchain in Life Sciences
    • RWE in Clinical Research
  • At the Peak
    • Wearable Devices for Clinical Trials
    • Augmented Analytics
    • Clinical Trial Data Transparency
    • Lab Apps
    • Machine Learning
    • SaaS-Regulated EDMS
    • Enterprise Laboratory Informatics
    • Genomics Medicine
  • Sliding Into the Trough
    • Adaptive Trials
    • Centralized Monitoring/RBM
    • Insight Engines
    • Patient Communities for Trial Recruitment
    • SaaS LIMS
    • 3D Bioprinting for Life Science R&D
    • SaaS ELN
    • Compliant GxP Cloud Services
    • Semantic Knowledge Graphing
    • RWD-Based Studies
    • Precompetitive Alliances
    • Innovation Management Technology for Product Development
    • Enterprise IP Management
  • Climbing the Slope
    • Pharma PLM
    • Text Analytics for Scientific Research
    • eTMF
    • Clinical Resource Management
    • E-Clinical Application Suites
    • Structured Content and Component Authoring
    • ELN
    • Global Regulatory Information Management
    • Medical Devices — PLM
    • Scientific Analytics Platforms
  • Entering the Plateau
    • ePRO, E-Patient Diaries and eCOA
    • Signal Detection
  • Appendixes
    • Hype Cycle Phases, Benefit Ratings and Maturity Levels

Gartner Recommended Reading

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.